Photys Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Photys Therapeutics is a biotechnology research company based in Waltham, Massachusetts, focused on controlling protein post-translational modifications with a bifunctional small-molecule platform. This approach aims to go beyond protein degradation by restoring function, repairing signaling, and amplifying the body's own disease-fighting mechanisms. The company was co-founded by Amit Choudhary of the Broad Institute and the Longwood Fund, and is guided by a scientific advisory board including MIT's Angela Koehler, Salk's Tony Hunter, Berkeley's Dan Nomura, MPM's Wendy Young, and Dana-Farber's Eric Fischer. 

Photys collaborates with pharmaceutical developers to advance proximity-based therapeutics, particularly for cardiometabolic diseases. In late 2024, it announced a research collaboration with Novo Nordisk to develop induced proximity therapeutics targeting a cardiometabolic disease pathway. The organization remains a small, specialized team pursuing collaboration-driven research.

Get verified Photys Therapeutics emails free

Company overview Employee directory